Clinical Trial Update: Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial update for relacorilant in combination with different regimens in gynecologic cancers; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Relacorilant (relacorilant)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: RECRUITING